R, D., A, Y., AE, B., E, B., RM, A., HC, T., . . . C, B. (2026). Real-world evidence on JAK inhibitors in rheumatology practice: Comparative safety, efficacy, and outcomes between JAK inhibitors. Clinical rheumatology. https://doi.org/10.1007/s10067-026-08251-3
Chicago Style (17th ed.) CitationR, Deniz, et al. "Real-world Evidence on JAK Inhibitors in Rheumatology Practice: Comparative Safety, Efficacy, and Outcomes Between JAK Inhibitors." Clinical Rheumatology 2026. https://doi.org/10.1007/s10067-026-08251-3.
MLA (9th ed.) CitationR, Deniz, et al. "Real-world Evidence on JAK Inhibitors in Rheumatology Practice: Comparative Safety, Efficacy, and Outcomes Between JAK Inhibitors." Clinical Rheumatology, 2026, https://doi.org/10.1007/s10067-026-08251-3.